Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • karl_s
    Junior Member
    • Dec 2013
    • 9

    #1

    de-novo differential transcription/splicing question

    Hi folks,
    I am relatively new to this kind of analysis. I am interested in discovering novel splice variants and differentially transcribed genes. I have several pairs of inputs (pre and post relapse CLL for 3 individuals). I am using STAR to map paired reads to hg19 without a GTF file. I also am using cufflinks/cuffcompare/cuffdiff to look for differential events. Is there an easy way to remove known transcript variants from the output of cuffdiff so as to focus on the novel stuff? Or, should I be using STAR with an annotated set of indexes and using a GTF file in the search? For example, to create the index for STAR:

    STAR --runMode genomeGenerate --sjdbFileChrStartEnd hg19_intron_loci.txt --sjdbOverhang 75 --genomeDir ../blabla.fa

    then to run it on a pair of reads:

    STAR --genomeDir /data/Genomes/UCSC/hg19/STAR_ANNOTATED --sjdbGTFfile /data/Genomes/UCSC/hg19/knownGene_standardchromonly.gtf --readFilesIn sample1_1.clipped.fastq sample1_2.clipped.fastq --runThreadN 32

    Or is there a better way? BTW I can already do the general differential expression analysis using a mapping to the transcriptome (i.e using BWA-eXpress and edgeR, or inverse beta binomial for the statistical test).

    I'm also using diffsplice on the star output, and that is kind of interesting. I annotate the regions with annovar.

    cheers,
    karl_s
  • karl_s
    Junior Member
    • Dec 2013
    • 9

    #2
    OK, i think i figured out part of this. It seems that cuffcompare is used with the -r flag to compare to a reference, and the output has some flags to indicate how the transcripts are related to a known set of transcripts. Providing annotation in the mapping step maybe just helps the mappers accuracy.

    Anyhow comments on this sort of analysis from more experienced folks would be welcome. Generally, the quesiton I am trying to answer is, given two biological conditions, am I seeing anything new.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...